29 Apr 20 | All | Gedeon Richter, Mycenax | Gedeon Richter announces it has entered an asset purchase agreement with Mycenax Biotech for the purchase of a biosimilar tocilizumab product. Under the agreement, Richter will receive worldwide rights to develop, manufacture...

Please reload

Biosimilars bulletin 

November 9, 2020

Please reload

Search by tags